Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Economic Evaluation of Stream™ Platform

NCT: NCT05994625 · ACTIVE_NOT_RECRUITING

NCT IDNCT05994625
StatusACTIVE_NOT_RECRUITING
Start Date2023-12-06
Completion2027-12
SponsorFluidAI Medical (INDUSTRY)
First posted
Last updated

Brief Summary

This Economic Evaluation study is a multi-center, two-arm, non-randomized, interventional trial. The purpose of this study is to evaluate the economic and patient outcomes of using the Stream™ Platform for early detection of anastomotic leakage after gastrointestinal surgery. The trial will track patient outcomes and healthcare costs in two groups: the intervention group, where the Stream platform is deployed, and the control group, before the integration of the Stream™ Platform. The data collected from both groups will be compared to assess the impact of implementing the Stream™ Platform and early leak detection on overall patient outcomes and healthcare costs.This trial will include hepatobiliary, colorectal, and trauma/acute care patient populations.

Frequently Asked Questions

What is Economic Evaluation of Stream™ Platform?

Economic Evaluation of Stream™ Platform is a clinical trial registered under NCT05994625. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05994625?

The current status of NCT05994625 (Economic Evaluation of Stream™ Platform) is: ACTIVE_NOT_RECRUITING.

When did Economic Evaluation of Stream™ Platform start?

Economic Evaluation of Stream™ Platform started on 2023-12-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.